Additionally, GLP-1 has neurological effects that decrease appetite, increase satiety, and reduce the desire for food [1]
Brand-name GLP-1s often require prior authorization, and initial denials are common
Retatrutide is an investigational triple receptor agonist still in clinical trials, while GHK-Cu is a copper-binding tripeptide used legally only in topical cosmetics in the UK
Most chronic illnesses are acceptable as long as you feel well, the condition is under control, and you meet all other eligibility requirements
General principles for transdermal patch application include: Choose an appropriate site : Common application areas for transdermal medications typically include the abdomen, upper arm, or thigh
They go above and beyond to make you feel valued as a customer and that goes a long way